Literature DB >> 30887090

[Elimination of measles in the WHO European Region-challenges persist].

Mark Muscat1, Myriam Ben Mamou2, Simarjit Singh2, Catharina de Kat2, Dragan Jankovic2, Shahin Huseynov2, Sergei Deshevoi2, Siddhartha Datta2, Patrick O'Connor2.   

Abstract

BACKGROUND: Measles incidence in the 53 Member States of the World Health Organization (WHO) European Region has fallen dramatically in recent decades. The European Regional Verification Commission for Measles and Rubella Elimination (RVC) verified that 43 member states had interrupted endemic measles transmission for ≥12 months by the end of 2017. However, measles incidence in the region increased sharply in 2018 compared to 2017. The purpose of this article is to assess the current status of measles in the Region in relation to its elimination goal. It also discusses challenges and actions needed to reach this goal.
METHODS: Measles surveillance data presented for 2017 and 2018 (as of 1 February 2019) were submitted by all 53 member states. The measles elimination status of countries was obtained from the 2018 report of the seventh meeting of the RVC.
RESULTS: In 2017, 25,863 measles cases were reported in 44 countries of the WHO European Region. In 2018, 82,596 measles cases were reported in 47 countries. Most cases were reported by Ukraine (64%) and Serbia (6%). Age was known in 82,588 cases: 8% were <1 year old, 17% were 1-4 years old, 38% were 5-19 years old and 37% were ≥20 years old. Data on vaccination status were provided for 76% of the cases, of which 62% were unvaccinated. Seventy-two measles-related deaths were reported from 10 countries.
CONCLUSIONS: For the elimination of measles in the European Region, a high population immunity rate and accurate epidemiological surveillance remain essential. Long-term political commitment by all Member States in these areas is crucial to attain the elimination goal.

Entities:  

Keywords:  Disease elimination; Genotyping; Measles; Surveillance; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 30887090     DOI: 10.1007/s00103-019-02920-2

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  12 in total

1.  Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.

Authors:  P Albrecht; F A Ennis; E J Saltzman; S Krugman
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Secondary failure rates of measles vaccines: a metaanalysis of published studies.

Authors:  J F Anders; R M Jacobson; G A Poland; S J Jacobsen; P C Wollan
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

3.  Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.

Authors:  Susan J M Hahné; Laura M Nic Lochlainn; Nathalie D van Burgel; Jeroen Kerkhof; Jussi Sane; Kioe Bing Yap; Rob S van Binnendijk
Journal:  J Infect Dis       Date:  2016-10-07       Impact factor: 5.226

4.  Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.

Authors:  M Hirose; Y Hidaka; C Miyazaki; K Ueda; H Yoshikawa
Journal:  Scand J Infect Dis       Date:  1997

5.  Death certification errors at an academic institution.

Authors:  Bobbi S Pritt; Nicholas J Hardin; Jeffrey A Richmond; Steven L Shapiro
Journal:  Arch Pathol Lab Med       Date:  2005-11       Impact factor: 5.534

6.  The role of secondary vaccine failures in measles outbreaks.

Authors:  R G Mathias; W G Meekison; T A Arcand; M T Schechter
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

7.  Measles outbreak in a French Roma community in the Provence-Alpes-Côte d'Azur region, France, May to July 2017.

Authors:  Raphael Godefroy; Pascal Chaud; Laetitia Ninove; Julia Dina; Anne Decoppet; Paul Casha; Sami Hraiech; Philippe Brouqui; Nadim Cassir
Journal:  Int J Infect Dis       Date:  2018-09-07       Impact factor: 3.623

8.  Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.

Authors:  Kristen A Wendorf; Kathleen Winter; Jennifer Zipprich; Rob Schechter; Jill K Hacker; Chris Preas; James D Cherry; Carol Glaser; Kathleen Harriman
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

9.  Ongoing measles outbreak in Greece related to the recent European-wide epidemic.

Authors:  T Georgakopoulou; E Horefti; A Vernardaki; V Pogka; K Gkolfinopoulou; E Triantafyllou; S Tsiodras; M Theodoridou; A Mentis; T Panagiotopoulos
Journal:  Epidemiol Infect       Date:  2018-08-08       Impact factor: 4.434

10.  Nosological Inaccuracies in death certification in Northern Ireland. A comparative study between hospital doctors and general practitioners.

Authors:  A Armour; H Bharucha
Journal:  Ulster Med J       Date:  1997-05
View more
  4 in total

1.  The 2019 measles epidemic in Bosnia and Herzegovina: What is wrong with the mandatory vaccination program?

Authors:  Jurica Arapović; Željana Sulaver; Borko Rajič; Aida Pilav
Journal:  Bosn J Basic Med Sci       Date:  2019-08-20       Impact factor: 3.363

Review 2.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

3.  Mandatory vaccination: suited to enhance vaccination coverage in Europe?

Authors:  Heidemarie Holzmann; Ursula Wiedermann
Journal:  Euro Surveill       Date:  2019-06

Review 4.  [The global measles crisis-a diversity of causes from armed conflicts to vaccination skepticism].

Authors:  Luisa Denkel; Werner Espelage; Dorothea Matysiak-Klose; Thomas Morwinsky; Anette Siedler; Sandra Beermann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-11-13       Impact factor: 1.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.